22071-00-7 Usage
Uses
Used in Pharmaceutical Industry:
(E)-ethyl 3-amino-4,4,4-trichloro-2-isocyanobut-2-enoate is used as a building block for the production of various pharmaceuticals. Its unique structure allows it to be a key intermediate in the synthesis of a wide range of medicinal compounds, contributing to the development of new drugs and therapies.
Used in Agrochemical Industry:
In the agrochemical sector, (E)-ethyl 3-amino-4,4,4-trichloro-2-isocyanobut-2-enoate is utilized as a starting material for the synthesis of different agrochemicals. Its reactivity enables the creation of compounds that can be used in the development of pesticides, herbicides, and other agricultural products to enhance crop protection and yield.
Used in Chemical Research:
(E)-ethyl 3-amino-4,4,4-trichloro-2-isocyanobut-2-enoate is also employed in chemical research as a valuable intermediate. Its properties make it suitable for exploring new reaction pathways and understanding the behavior of isocyanate derivatives in various chemical processes.
Safety Precautions:
It is crucial to handle (E)-ethyl 3-amino-4,4,4-trichloro-2-isocyanobut-2-enoate with care due to its highly reactive nature as an isocyanate. It can cause irritation to the skin, eyes, and respiratory system. Therefore, proper safety measures, including the use of personal protective equipment and adherence to handling procedures, should be strictly followed to ensure the safety of individuals working with (E)-ethyl 3-aMino-4,4,4-trichloro-2-isocyanobut-2-enoate.
Check Digit Verification of cas no
The CAS Registry Mumber 22071-00-7 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,2,0,7 and 1 respectively; the second part has 2 digits, 0 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 22071-00:
(7*2)+(6*2)+(5*0)+(4*7)+(3*1)+(2*0)+(1*0)=57
57 % 10 = 7
So 22071-00-7 is a valid CAS Registry Number.
22071-00-7Relevant academic research and scientific papers
Larotinib derivative and preparation method and application thereof
-
Paragraph 0061-0062; 0070, (2020/09/16)
The invention relates to a larotinib derivative and a preparation method and application thereof, and provides a novel larotinib derivative with anti-tumor activity. The novel larotinib derivative isbeneficial to improving the anti-tumor activity of the l
MACROCYCLIC COMPOUNDS AND USES THEREOF
-
Paragraph 0250; 0251, (2019/02/13)
The present disclosure relates to certain macrocyclic compounds that inhibit SRC and MET, and/or CSF1R, pharmaceutical compositions containing such compounds, and methods of using such compounds to treat cancer.
PI3 KINASE INHIBITORS AND USES THEREOF
-
Paragraph 00210, (2019/02/15)
Described herein are PI3 Kinase inhibitors and pharmaceutical compositions comprising said compounds. The subject compounds and compositions are useful for the treatment of cancer, cardiovascular diseases, and inflammatory diseases.
5-CHLORO-2-DIFLUOROMETHOXYPHENYL PYRAZOLOPYRIMIDINE COMPOUNDS, COMPOSITIONS AND METHODS OF USE THEREOF
-
Paragraph 0478, (2015/12/05)
Compounds of Formula (00A) and methods of use as Janus kinase inhibitors are described herein.
